Travere Therapeutics, Inc. Insider Trading for November 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Travere Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Travere Therapeutics, Inc. for November 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 25 2014 | RTRX | Retrophin, Inc. | Meckler Jeffrey A | Director | Buy | P | 8.60 | 15,000 | 129,050 | 35,000 | 20 K to 35 K (+75.00 %) |
| Nov 24 2014 | RTRX | Retrophin, Inc. | Shkreli Martin | Option Exercise | J | 0.00 | 205,000 | 0 | 205,000 | ||
| Nov 24 2014 | RTRX | Retrophin, Inc. | Shkreli Martin | Option Exercise | J | 0.00 | 123,000 | 0 | 123,000 | ||
| Nov 24 2014 | RTRX | Retrophin, Inc. | Shkreli Martin | Sell | S | 8.41 | 252,847 | 2,126,443 | 1,765,168 | 2 M to 1.8 M (-12.53 %) | |
| Nov 24 2014 | RTRX | Retrophin, Inc. | Shkreli Martin | Sell | S | 8.23 | 134,354 | 1,105,989 | 2,018,015 | 2.2 M to 2 M (-6.24 %) | |
| Nov 24 2014 | RTRX | Retrophin, Inc. | Shkreli Martin | Sell | S | 8.54 | 329,824 | 2,817,093 | 2,152,369 | 2.5 M to 2.2 M (-13.29 %) | |
| Nov 24 2014 | RTRX | Retrophin, Inc. | Shkreli Martin | Sell | S | 9.19 | 254,975 | 2,343,501 | 2,482,193 | 2.7 M to 2.5 M (-9.32 %) | |
| Nov 24 2014 | RTRX | Retrophin, Inc. | Shkreli Martin | Sell | S | 9.41 | 100,000 | 941,100 | 2,737,168 | 2.8 M to 2.7 M (-3.52 %) | |
| Nov 24 2014 | RTRX | Retrophin, Inc. | Shkreli Martin | Sell | S | 10.23 | 100,000 | 1,022,790 | 2,837,168 | 2.9 M to 2.8 M (-3.40 %) | |
| Nov 24 2014 | RTRX | Retrophin, Inc. | Richardson Steven Gary | Director | Buy | P | 8.38 | 6,100 | 51,118 | 129,165 | 123.1 K to 129.2 K (+4.96 %) |
| Nov 21 2014 | RTRX | Retrophin, Inc. | ASELAGE STEVE | Chief Executive Off ... | Buy | P | 8.50 | 8,700 | 73,950 | 371,756 | 363.1 K to 371.8 K (+2.40 %) |
| Nov 21 2014 | RTRX | Retrophin, Inc. | ASELAGE STEVE | Chief Executive Off ... | Buy | P | 8.20 | 1,300 | 10,660 | 363,056 | 361.8 K to 363.1 K (+0.36 %) |
| Nov 19 2014 | RTRX | Retrophin, Inc. | Golding Cornelius E | Director | Buy | P | 9.00 | 2,000 | 18,000 | 25,000 | 23 K to 25 K (+8.70 %) |
| Nov 19 2014 | RTRX | Retrophin, Inc. | Plotkin Horacio | Chief Medical Offic ... | Sell | S | 9.43 | 8,333 | 78,594 | 93,867 | 102.2 K to 93.9 K (-8.15 %) |
| Nov 17 2014 | RTRX | Retrophin, Inc. | VALEUR JENSEN MARGARET E | General Counsel | Grant | A | 0.00 | 100,000 | 0 | 100,000 | 0 to 100 K |
| Nov 17 2014 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Option Exercise | A | 9.45 | 100,000 | 945,000 | 100,000 | |
| Nov 10 2014 | RTRX | Retrophin, Inc. | Richardson Steven Gary | Director | Option Exercise | A | 10.09 | 25,000 | 252,250 | 25,000 | |
| Nov 10 2014 | RTRX | Retrophin, Inc. | Richardson Steven Gary | Director | Grant | A | 0.00 | 20,000 | 0 | 122,065 | 102.1 K to 122.1 K (+19.60 %) |
| Nov 10 2014 | RTRX | Retrophin, Inc. | Golding Cornelius E | Director | Option Exercise | A | 10.09 | 25,000 | 252,250 | 25,000 | |
| Nov 10 2014 | RTRX | Retrophin, Inc. | Golding Cornelius E | Director | Grant | A | 0.00 | 20,000 | 0 | 23,000 | 3 K to 23 K (+666.67 %) |
| Nov 10 2014 | RTRX | Retrophin, Inc. | ASELAGE STEVE | Chief Executive Off ... | Option Exercise | A | 10.09 | 300,000 | 3,027,000 | 300,000 | |
| Nov 10 2014 | RTRX | Retrophin, Inc. | ASELAGE STEVE | Chief Executive Off ... | Grant | A | 0.00 | 100,000 | 0 | 361,756 | 261.8 K to 361.8 K (+38.20 %) |